The PKD Foundation Research Grants fund innovative research into the biology, mechanisms, and treatment of polycystic kidney disease across basic to clinical science.
Funder: PKD Foundation
Due Dates: August 17, 2026: Pre-application (Letter of Intent) deadline | January 19, 2027: Full application deadline
Funding Amounts: Up to $120,000/year for 2 years ($240,000 total); optional third year (Young Investigator Award) for $360,000 total
Summary: Supports innovative research advancing understanding and treatment of polycystic kidney disease (PKD) across basic, translational, clinical, and data-driven disciplines.
Key Information: Pre-application is required; only invited applicants may submit a full proposal.
The PKD Foundation Research Grants program funds basic, translational, clinical, and epidemiological research that benefits individuals affected by autosomal dominant (ADPKD) and autosomal recessive (ARPKD) polycystic kidney disease. The program aims to catalyze innovative projects that deepen understanding of PKD’s molecular mechanisms, accelerate therapeutic development, and improve patient outcomes. Proposals are encouraged in diverse areas including molecular pathobiology, gene therapies, cilia signaling, machine learning, extra-renal manifestations, drug delivery, and lifestyle interventions. Special consideration is given to research conducted in Canada and Australia.